Company / Net Income
Supernus Pharmaceuticals, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$38.5M
FY2025
5-year range
-$38.5M / $73.9M
FY2021-FY2025
Trend
-152.2%
vs FY2024
Sector context
#79 of 216
Health Care
What the data says
At -$39M, Supernus Pharmaceuticals, Inc.'s net income ranks #79 of 216 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$39M in FY2025 to $127M in FY2020.
Based on SEC 10-K filings.
-$39M in FY2025.
Declined from $1M to -$39M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#79 of 216 in Health CareTop 37% of 216This company -$38.5M Sector average $454.3M
▼
-108.5% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 152.2% year-over-year.
- Ranks #79 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$38.5M | -152.2% |
| FY2024 | $73.9M | +5512.8% |
| FY2023 | $1.3M | -97.8% |
| FY2022 | $60.7M | +13.6% |
| FY2021 | $53.4M | -57.9% |
| FY2020 | $127.0M | +12.3% |
| FY2019 | $113.1M | +23.9% |
| FY2018 | $91.2M | +554.2% |
| FY2017 | $13.9M | +227.6% |
| FY2016 | -$10.9M | -178.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026